NCT06206083View on ClinicalTrials.gov

Molecular Classification in Mexican Patients With Endometrial Cancer and Its Impact on Prognosis

RecruitingOBSERVATIONAL

Enrollment

64

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

November 1, 2026

Study Completion Date

February 1, 2027

Conditions

Endometrial Cancer

Interventions

GENETIC

Descriptive and analytical

Patients with EC endometroid

Trial Locations (1)

14080

RECRUITING

Instituto Nacional de Cancerología, Mexico City

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

National Institute of Cancerología

OTHER_GOV

NCT06206083 - Molecular Classification in Mexican Patients With Endometrial Cancer and Its Impact on Prognosis | Biotech Hunter | Biotech Hunter